[ad_1] Investing.com — Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week. InvestingPro subscribers always get first dibs on market-moving AI analyst comments. Upgrade today! Roblox What happened? On Monday, Morgan Stanley upgraded Roblox Corp (NYSE:) to Overweight with a $65 price target *TLDR: Morgan Stanley sets Roblox target multiple at 25% premium. Bullish scenario values Roblox at $110 per share. What’s the full story? Morgan Stanley has set a target multiple for Roblox that represents a 25% premium compared to its internet peers. The bulge bracket bank justifies this premium by…
Author: user
[ad_1] By Ted Hesson, Kristina Cooke WASHINGTON (Reuters) -Donald Trump is expected to mobilize agencies across the U.S. government to help him deport record numbers of immigrants, building on efforts in his first term to tap all available resources and pressure so-called “sanctuary” jurisdictions to cooperate, according to six former Trump officials and allies. Trump defeated Democrat Kamala Harris in a stunning political comeback, Edison Research projected, telling supporters America had given him an “unprecedented and powerful mandate.” Trump backers – including some who could enter his second administration – anticipate the Republican president-elect will call on everyone from the U.S.…
[ad_1] This index fund is outperforming the S&P 500 this year. The stock market has soared this year, with the S&P 500 confirming its presence in a bull market back in January and then going on to reach multiple record highs. The good news is history shows us that bull markets generally last much longer than bear phases, so this positive momentum could continue for quite some time. What types of stocks should you buy in this environment? Growth stocks generally lead the way in times of market optimism, and so far, that is what’s happened this time around, too. You…
[ad_1] Bitcoin (BTC) jumped above the $79,000 mark for the first time in history in an unusual weekend pump that liquidated $280 million in bearish crypto trades. BTC rose 4%, extending 7-day gains to over 16% on the back of a week that saw Republican Donald Trump elected the U.S. president and Federal Reserve cutting rates by 25 basis points — with both events considered widely bullish among traders. Weekend pumps are generally considered bullish in the crypto market, as trading volumes typically decrease over the weekend when many institutional investors and professional traders are less active. Lower liquidity can…
[ad_1] Image source: Getty Images The main reason I invest is to build a lifelong passive income to top up my State Pension and secure a comfortable retirement. I don’t plan to touch my investments until I’m in my late 60s, to give them maximum time to grow. Someone who starts working in their early 20s potentially has 45 years to build up a decent retirement pot. In my view, the stock market is the ideal way to build long-term wealth. In the short term, it’s volatile. But in the longer run, it delivers more income and growth than any…
[ad_1] Investing.com — In a Wednesday note to clients, Citi economists discussed the potential impact of a 60% tariff on Chinese goods entering the US market, a measure that has gained attention following the projection of Donald Trump’s victory in the presidential election. The report outlines that such a tariff could lead to a significant reduction in Chinese exports to the US potentially decreasing China’s GDP growth by approximately 2.4 percentage points in an extreme scenario. However, Citi believes that a universal 60% tariff is more likely a negotiating tactic rather than an imminent policy change. “The proposal of a…
[ad_1] Goldman Sachs has upgraded BioNTech SE BNTX, citing the company’s BNT327, an immuno-oncology asset in clinical development across multiple solid tumors. Data from Summit Therapeutics Inc. SMMT and their partner Akeso for ivonescimab (PD-1xVEGF bispecific) has shown the potential to challenge standard-of-care regimens across a range of solid tumors. The analyst notes that the data for ivonescimab have sparked interest in BioNTech’s bispecific drug, BNT327, and its potential to follow a similar path and gain value. Also Read: BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3 The analyst adds that the data for BNT327, including the latest findings presented…
[ad_1] Microsoft could see a windfall from its investments in artificial intelligence start-up OpenAI. In 2019, Microsoft (MSFT -0.68%) invested its first $1 billion in OpenAI, a San Francisco-based start-up focused on artificial intelligence (AI). At the time, Microsoft worried it had fallen “multiple years behind the competition in terms of machine learning,” according to messages between Chief Technology Officer Kevin Scott, CEO Satya Nadella, and co-founder Bill Gates. In particular, Microsoft was worried about recent technological advancements made by Alphabet’s Google, a long-standing leader in AI research through its DeepMind subsidiary. Microsoft pounced on what it saw as a…
[ad_1] Suze Orman had some strong words for a listener who considered drastically changing her IRA’s investment strategy. In a recent episode of the Women & Money podcast, a listener named Jane shared her concerns about the current state of the market and asked Orman if it would be smart to sell all her current IRA investments. Don’t Miss: Jane said the idea behind this would be to place the proceeds into a money-market fund within the IRA, then dollar-cost average back into the market over time, assuming prices might decline shortly. Orman responded directly: “It’s the worst idea I’ve…
[ad_1] Image source: Getty Images The FTSE 250 may tend to be more volatile than its larger cousin, the FTSE 100, but it can provide investors with greater opportunities for outsized returns. Leading consumer brands There are not many companies that can boast a host of market-leading brands in their portfolio. PZ Cussons (LSE: PZC) can, though. These include Imperial Leather, Original Source, Carex, and Sanctuary Spa. Despite being home to a suite of top brands, this is a company that has struggled to make itself relevant against much larger competitors, including Procter & Gamble and Unilever. Since peaking at…